Assembly Biosciences Inc.

NASDAQ: ASMB · Real-Time Price · USD
25.29
0.33 (1.32%)
At close: Aug 15, 2025, 3:59 PM
25.50
0.85%
After-hours: Aug 15, 2025, 07:52 PM EDT

Assembly Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-10.2M -8.82M -10.34M -9.61M -11.15M -9.08M -10.96M -14.42M -16.9M -18.95M -22.39M -23.14M -24.46M -23.09M -60.26M -18.8M -23.59M -27.2M
Depreciation & Amortization
32K 33K 32K 33K 32K 32K 84K 116K 126K 124K 124K 134K 120K 120K 120K 119K 120K 107K
Stock-Based Compensation
834K 712K 751K 797K 833K 739K 959K 1.14M 1.19M 1.83M 2.01M 1.56M 1.58M 1.44M 1.95M 1.59M 1.99M -286K
Other Working Capital
n/a -15.37M 10.13M 14.83M -6.33M -9.42M 83.84M -1.08M 4.34M 1.04M -631K 1.99M 2.87M -5.58M 1.64M 173.29M 191.65M 207.14M
Other Non-Cash Items
-7.43M -9.42M -240K -21.82M 174K -368K 1.54M 514K -2.27M 803K 782K 880K 956K 1.04M 39.73M 903K 902K 1.14M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -1.47M -313K -169K n/a n/a n/a n/a n/a -2.53M 149K 171K 1.7M
Change in Working Capital
n/a -15.08M 9.38M 15.36M -6.21M -9.15M 83.5M -880K 4.39M -7.24M 222K 753K 3.92M -7.02M 1.64M -2.84M -1.39M -8.8M
Operating Cash Flow
-16.76M -23.44M -407K -15.24M -17.1M -18.36M 73.65M -13.85M -13.63M -23.43M -19.25M -19.82M -17.89M -27.5M -19.36M -18.88M -21.81M -33.34M
Capital Expenditures
n/a n/a n/a n/a -14K -14K -71K -136K -48K n/a -102K -102K n/a n/a -18K n/a n/a -3.08M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 24K -19.02K 48K n/a n/a -31.53K n/a n/a 586K n/a n/a 857K
Purchase of Investments
-17.89M -20.35M -40.9M -17.78M -31.18M -3.71M -108.31M -2.65M -22.96M -52K -8.76M -2.97M -11.9M -3.95M -52.97M -22.68M -35.59M -49.21M
Sales Maturities Of Investments
34.5M 26.43M 34.2M 39.2M 36.3M 21M 18.7M 21.67M 14.64M 10M 23.82M 34.5M 21.5M 37M 43M 42.75M 32.5M 69.45M
Other Investing Acitivies
379K 508K n/a 3.06M 5.12M 1.26M -89.58M 19.02K -48K 52K 1.6M 31.53K 9.6M 33.05M 914K 20.07M -3.09M 857K
Investing Cash Flow
16.99M 6.59M -6.7M 24.49M 5.11M 17.27M -89.65M 18.88M -8.37M 10M 16.56M 31.43M 9.6M 33.05M -8.48M 20.07M -3.09M 18.02M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
357K n/a 96K -12.39M 59K n/a 49K n/a 80K n/a 112K n/a 177K n/a 114K n/a 144K n/a
Financial Cash Flow
357K 1.92M 17M n/a 12.45M n/a 9.19M n/a 134K 4.49M 437K n/a 177K n/a 2.71M 10.05M 6.16M 34.14M
Net Cash Flow
593K -14.93M 9.89M 9.24M 459K -1.09M -4.12M 5.03M -21.86M -8.94M -2.25M 11.61M -8.11M 5.55M -25.13M 11.24M -18.74M 18.81M
Free Cash Flow
-16.76M -23.44M -407K -15.24M -17.12M -18.38M 73.58M -13.98M -13.68M -23.43M -19.36M -19.92M -17.89M -27.5M -19.38M -18.88M -21.81M -36.42M